Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TVTX | KNSA | MANE | ||
| Company | Travere Therapeutics Inc | Kiniksa Pharmaceuticals International Plc | Veradermics Incorporated | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 45.51 | 57.62 | 109.57 | ||
| High | 45.97 | 57.62 | 112.85 | ||
| Low | 42.18 | 55.76 | 106.48 | ||
| Latest | 42.66 | 56.93 | 107.85 | ||
| Change | -2.10 | -1.30 | -1.92 | ||
| % Change | -4.69% | -2.23% | -1.75% | ||
| Volume | 10,827,600 | 545,300 | 592,300 | ||
| 20-Day Average Volume | 3,398,495 | 919,830 | 794,585 | ||
| Previous Close | 44.76 | 58.23 | 109.77 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 40.44 | 49.01 | 87.41 | ||
| 20-Day Raw Stochastic | 70.72% | 92.07% | 83.14% | ||
| 20-Day Relative Strength | 62.87 | 67.31 | 68.10 | ||
| Weighted Alpha | +76.27 | +98.94 | N/A | ||
| Today's Opinion | 100% Buy | 100% Buy | N/A | ||
| Previous Opinion | 100% Buy | 100% Buy | N/A | ||
| Last Month's Opinion | 24% Buy | 100% Buy | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.28% since 04/30/26 | +5.86% since 04/30/26 | +8.94% since 04/30/26 | ||
| Low | 42.08 on 05/01/26 | 52.76 on 05/01/26 | 95.51 on 05/01/26 | ||
| High | 48.61 on 05/05/26 | 58.26 on 05/06/26 | 117.71 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | +34.70% since 04/07/26 | +16.33% since 04/07/26 | +90.18% since 04/07/26 | ||
| Low | 28.29 on 04/10/26 | 41.49 on 04/21/26 | 53.68 on 04/08/26 | ||
| High | 48.61 on 05/05/26 | 58.26 on 05/06/26 | 117.71 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | +43.59% since 02/06/26 | +32.12% since 02/06/26 | +180.28% since 02/06/26 | ||
| Low | 26.15 on 03/20/26 | 41.12 on 02/24/26 | 36.26 on 02/09/26 | ||
| High | 48.61 on 05/05/26 | 58.26 on 05/06/26 | 117.71 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | +31.91% since 11/07/25 | +48.37% since 11/07/25 | N/A since 02/04/26 | ||
| Low | 22.59 on 01/13/26 | 37.02 on 01/15/26 | 32.00 on 02/04/26 | ||
| High | 48.61 on 05/05/26 | 58.26 on 05/06/26 | 117.71 on 05/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,162,366 | 4,456,633 | 4,098,812 | ||
| Shares Outstanding, K | 92,993 | 76,535 | 37,340 | ||
| Annual Sales | 490,730,000 | 677,560,000 | 0 | ||
| Annual Net Income | -25,550,000 | 59,010,000 | -69,995,000 | ||
| Last Quarter Sales | 129,690,000 | 214,270,000 | 0 | ||
| Last Quarter Net Income | 2,730,000 | 22,590,000 | -21,847,000 | ||
| 60-Month Beta | 1.13 | 0.17 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 05/04/26 | 0.27 on 04/28/26 | N/A on 03/30/26 | ||
| Earnings Date | 08/05/26 | 08/04/26 | 06/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 63.04 | 0.00 | ||